{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:43:58Z","timestamp":1793036638326,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017590","name":"Hubei University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.intimp.2025.115383","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T15:23:20Z","timestamp":1755962600000},"page":"115383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["BOLA3 as a key protein for the treatment of diabetic skeletal muscle atrophy"],"prefix":"10.1016","volume":"164","author":[{"given":"Leiming","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115383_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"74","key":"10.1016\/j.intimp.2025.115383_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2337\/db24-0691","article-title":"N 6-methyladenosine demethylase FTO controls macrophage homeostasis in diabetic vasculopathy","volume":"1","author":"Feng","year":"2025","journal-title":"Diabetes"},{"issue":"68","key":"10.1016\/j.intimp.2025.115383_bb0015","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/db18-0416","article-title":"FoxO transcription factors are critical regulators of diabetes-related muscle atrophy","volume":"3","author":"O\u2019Neill","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2025.115383_bb0020","article-title":"The role of the farnesoid X receptor in diabetes and its complications","author":"Zhang","year":"2024","journal-title":"Mol. Cell. Biochem."},{"issue":"33","key":"10.1016\/j.intimp.2025.115383_bb0025","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2337\/dc09-2310","article-title":"Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS)","volume":"7","author":"Kim","year":"2010","journal-title":"Diabetes Care"},{"issue":"320","key":"10.1016\/j.intimp.2025.115383_bb0030","doi-asserted-by":"crossref","first-page":"E680","DOI":"10.1152\/ajpendo.00275.2020","article-title":"MOTS-c reduces myostatin and muscle atrophy signaling","volume":"4","author":"Kumagai","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2025.115383_bb0035","doi-asserted-by":"crossref","DOI":"10.22271\/bs.book.76","article-title":"Salbutamol Attenuates Diabetic Skeletal Muscle Atrophy by Reducing Oxidative Stress, Myostatin\/GDF-8, and Pro-Inflammatory Cytokines in Rats","volume":"8. 15","author":"Kumar","year":"2023","journal-title":"Pharmaceutics"},{"issue":"179","key":"10.1016\/j.intimp.2025.115383_bb0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/bph.15693","article-title":"Butyrate ameliorates skeletal muscle atrophy in diabetic nephropathy by enhancing gut barrier function and FFA2-mediated PI3K\/Akt\/mTOR signals","volume":"1","author":"Tang","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"62","key":"10.1016\/j.intimp.2025.115383_bb0045","article-title":"Resveratrol Improves Muscle Atrophy by Modulating Mitochondrial Quality Control in STZ-Induced Diabetic Mice","volume":"9","author":"Wang","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"issue":"13","key":"10.1016\/j.intimp.2025.115383_bb0050","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/jcsm.12950","article-title":"Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy","volume":"3","author":"Alves","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"139","key":"10.1016\/j.intimp.2025.115383_bb0055","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1161\/CIRCULATIONAHA.119.040134","article-title":"Mitochondrial Function, Skeletal Muscle Metabolism, and Iron Deficiency in Heart Failure","volume":"21","author":"van der Meer","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2025.115383_bb0060","article-title":"Atorvastatin Induces Mitochondria-Dependent Ferroptosis via the Modulation of Nrf2-xCT\/GPx4 Axis","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2025.115383_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114088","article-title":"Dapagliflozin attenuates skeletal muscle atrophy in diabetic nephropathy mice through suppressing Gasdermin D-mediated pyroptosis","volume":"148","author":"Zhang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115383_bb0070","article-title":"New Trends to Treat Muscular Atrophy: A Systematic Review of Epicatechin","volume":"2. 16","author":"German","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2025.115383_bb0075","article-title":"The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms","volume":"8. 10","author":"Massimino","year":"2021","journal-title":"Cells"},{"issue":"15","key":"10.1016\/j.intimp.2025.115383_bb0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jcsm.13381","article-title":"Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation","volume":"1","author":"Zhang","year":"2024","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.intimp.2025.115383_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2024.109780","article-title":"Luteolin alleviates muscle atrophy, mitochondrial dysfunction and abnormal FNDC5 expression in high fat diet-induced obese rats and palmitic acid-treated C2C12 myotubes","volume":"135","author":"Zhang","year":"2025","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.intimp.2025.115383_bb0090","article-title":"Iron-sulfur cluster deficiency can be sensed by IRP2 and regulates iron homeostasis and sensitivity to ferroptosis independent of IRP1 and FBXL5","volume":"22. 7","author":"Terzi","year":"2021","journal-title":"Sci. Adv."},{"issue":"300","key":"10.1016\/j.intimp.2025.115383_bb0095","article-title":"FDX2, an iron-sulfur cluster assembly factor, is essential to prevent cellular senescence, apoptosis or ferroptosis of ovarian cancer cells","volume":"9","author":"Miyahara","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 4","key":"10.1016\/j.intimp.2025.115383_bb0100","article-title":"Mdb-15. inhibiting the iron-sulfur cluster transporter abcb7 can potentiate cisplatin response in pediatric group 3 medulloblastomas by triggering ferroptosis","volume":"26","author":"Mahapatra","year":"2024","journal-title":"Neuro-Oncology"},{"issue":"551","key":"10.1016\/j.intimp.2025.115383_bb0105","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nature24637","article-title":"NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis","volume":"7682","author":"Alvarez","year":"2017","journal-title":"Nature"},{"issue":"137","key":"10.1016\/j.intimp.2025.115383_bb0110","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/brain\/awt328","article-title":"Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5","volume":"Pt 2","author":"Baker","year":"2014","journal-title":"Brain"},{"issue":"89","key":"10.1016\/j.intimp.2025.115383_bb0115","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ajhg.2011.08.011","article-title":"Mutations in iron-sulfur cluster scaffold genes NFU1 and BOLA3 cause a fatal deficiency of multiple respiratory chain and 2-oxoacid dehydrogenase enzymes","volume":"4","author":"Cameron","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"68","key":"10.1016\/j.intimp.2025.115383_bb0120","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1086\/318196","article-title":"A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13","volume":"2","author":"Seyda","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"51","key":"10.1016\/j.intimp.2025.115383_bb0125","doi-asserted-by":"crossref","first-page":"11797","DOI":"10.1093\/nar\/gkad842","article-title":"BOLA3 and NFU1 link mitoribosome iron-sulfur cluster assembly to multiple mitochondrial dysfunctions syndrome","volume":"21","author":"Zhong","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.intimp.2025.115383_bb0130","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"Impaired Iron-Sulfur Cluster Synthesis Induces Mitochondrial PARthanatos in Diabetic Cardiomyopathy","volume":"1","author":"Wang","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"issue":"13","key":"10.1016\/j.intimp.2025.115383_bb0135","article-title":"Downregulation of Iron-Sulfur Cluster Biogenesis May Contribute to Hyperglycemia-Mediated Diabetic Peripheral Neuropathy in Murine Models","volume":"9","author":"Wu","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.intimp.2025.115383_bb0140","doi-asserted-by":"crossref","unstructured":"R. Nechushtai, L. Rowland, O. Karmi, CISD3\/MiNT is required for complex I function, mitochondrial integrity, and skeletal muscle maintenance, Proc Natl Acad Sci U S A.22. 121 (2024) e2405123121. doi: 10.1073\/pnas.2405123121.","DOI":"10.1073\/pnas.2405123121"},{"key":"10.1016\/j.intimp.2025.115383_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102164","article-title":"Mitochondrial iron-sulfur clusters: Structure, function, and an emerging role in vascular biology","volume":"47","author":"Read","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2025.115383_bb0150","doi-asserted-by":"crossref","unstructured":"J. A. Zuris, Y. Harir, A. R. Conlan, Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein, Proc Natl Acad Sci U S A.32. 108 (2011) 13047-13052. doi: 10.1073\/pnas.1109986108.","DOI":"10.1073\/pnas.1109986108"},{"key":"10.1016\/j.intimp.2025.115383_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108652","article-title":"BOLA3 is a prognostic-related biomarker and correlated with immune infiltrates in lung adenocarcinoma","volume":"107","author":"Wang","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115383_bb0160","article-title":"Functional dissection of metabolic trait-associated gene regulation in steady state and stimulated human skeletal muscle cells","author":"Nishino","year":"2024","journal-title":"bioRxiv"}],"updated-by":[{"DOI":"10.1016\/j.intimp.2025.115456","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925013748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925013748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:51:33Z","timestamp":1758786693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925013748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":32,"alternative-id":["S1567576925013748"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115383","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.intimp.2025.115456","asserted-by":"object"}]},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BOLA3 as a key protein for the treatment of diabetic skeletal muscle atrophy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115383"}}